Skip to main content

Bank of New York Mellon Corp

Bank

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1390777 NEW YORK, NY

Position in ACAD

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$16,395,777
-$3,689,738 QoQ
Shares Held
736,558
-2.1% QoQ
Ownership
0.430%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 93.3110495032299.ToString("F0")% Shared 0.ToString("F0")% None 6.688950496770111.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. ACAD ranks #38 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACAD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,395,777 736,558
2025-12-31 $20,085,515 751,985
2025-09-30 $16,983,754 795,865
2025-06-30 $17,393,568 806,378
2025-03-31 $13,360,914 804,390
2024-12-31 $7,518,910 409,750
2024-09-30 $6,657,476 432,866
2024-06-30 $8,540,445 525,566
2024-03-31 $9,301,447 503,053
2023-12-31 $17,249,052 550,912
2023-09-30 $11,793,165 565,891
2023-06-30 $13,600,531 567,872
2023-03-31 $10,768,237 572,170
2022-12-31 $9,308,613 584,712
2022-09-30 $8,695,616 531,517
2022-06-30 $6,971,857 494,809
2022-03-31 $12,347,087 509,789
2021-12-31 $12,261,154 525,328
2021-09-30 $8,658,409 521,277
2021-06-30 $12,214,607 500,804
2021-03-31 $11,107,490 430,523
2020-09-30 $16,884,777 409,328
2020-06-30 $20,652,239 426,083
2020-03-31 $21,404,017 506,604